Development of a Stable Peptide-Based PET Tracer for Detecting CD133-Expressing Cancer Cells

[Image: see text] CD133 has been recognized as a prominent biomarker for cancer stem cells (CSCs), which promote tumor relapse and metastasis. Here, we developed a clinically relevant, stable, and peptide-based positron emission tomography (PET) tracer, [(64)Cu]CM-2, for mapping CD133 protein in sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Kuan, Ma, Xiaohui, Xie, Lin, Zhang, Yiding, Hanyu, Masayuki, Obata, Honoka, Zhang, Lulu, Nagatsu, Kotaro, Suzuki, Hisashi, Shi, Rui, Wang, Weizhi, Zhang, Ming-Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2021
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756568/
https://www.ncbi.nlm.nih.gov/pubmed/35036703
http://dx.doi.org/10.1021/acsomega.1c04711

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8756568/
https://www.ncbi.nlm.nih.gov/pubmed/35036703
http://dx.doi.org/10.1021/acsomega.1c04711

Ejemplares similares